Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Tziomalos, Konstantinos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Karagiannis, A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., et al. (2007).  Serum uric acid as an independent predictor of early death after acute stroke.. Circ J. 71(7), 1120-7.
Tziomalos, K., Giampatzis V., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2014).  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.. J Clin Hypertens (Greenwich). 16(4), 309-12.
Athyros, V. G., Tziomalos K., Karagiannis A., Anagnostis P., & Mikhailidis D. P. (2010).  Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Curr Drug Targets. 11(1), 122-35.
Alkagiet, S., & Tziomalos K. (2018).  Should all hypertensive patients be screened for primary aldosteronism?. Curr Hypertens Rev.
Karagiannis, A., Athyros V. G., Papageorgiou A., Tziomalos K., & Elisaf M. (2006).  Should atenolol still be recommended as first-line therapy for primary hypertension?. Hellenic J Cardiol. 47(5), 298-307.
Milonas, D., & Tziomalos K. (2018).  Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke.. Cardiovasc Hematol Disord Drug Targets. 18(2), 134-138.
Karagiannis, A., Tziomalos K., Papageorgiou A., Kakafika A. I., Pagourelias E. D., Anagnostis P., et al. (2008).  Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.. Expert Opin Pharmacother. 9(4), 509-15.
Vassiliadis, T., Mpoumponaris A., Vakalopoulou S., Giouleme O., Gkissakis D., Grammatikos N., et al. (2010).  Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival.. Hepatol Res. 40(2), 161-70.
Athyros, V. G., Tziomalos K., Florentin M., Karagiannis A., & Mikhailidis D. P. (2010).  Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?. Curr Med Res Opin. 26(4), 839-42.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Statin-fibrate combination for mixed dyslipidaemia: a limited option?. Curr Med Res Opin. 26(9), 2137-40.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Pagourelias E. D., Savvatianos S. D., Elisaf M., et al. (2007).  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.. Open Cardiovasc Med J. 1, 8-14.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.. Curr Vasc Pharmacol. 7(3), 264-6.
Athyros, V. G., Kakafika A. I., Tziomalos K., Papageorgiou A. A., & Karagiannis A. (2008).  Statins for the prevention of first or recurrent stroke.. Curr Vasc Pharmacol. 6(2), 124-33.
Tziomalos, K., Dimitriou P., Bouziana S. D., Spanou M., Kostaki S., Angelopoulou S-M., et al. (2017).  Stress hyperglycemia and acute ischemic stroke in-hospital outcome.. Metabolism. 67, 99-105.
T
Athyros, V. G., Mikhailidis D. P., Papageorgiou A. A., Didangelos T. P., Peletidou A., Kleta D., et al. (2005).  Targeting vascular risk in patients with metabolic syndrome but without diabetes.. Metabolism. 54(8), 1065-74.
Athyros, V. G., Gossios T. D., Tziomalos K., Florentin M., Karagiannis A., & Mikhailidis D. P. (2011).  Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?. Arch Med Sci. 7(6), 1067-75.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  To switch (statins) or not to switch? That is the question.. Expert Opin Pharmacother. 11(18), 2943-6.
Tziomalos, K., Vakalopoulou S., Perifanis V., & Garipidou V. (2009).  Treatment of congenital fibrinogen deficiency: overview and recent findings.. Vasc Health Risk Manag. 5, 843-8.
Krikis, N., Tziomalos K., Perifanis V., Vakalopoulou S., Karagiannis A., Garypidou V., et al. (2004).  Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol.. Hormones (Athens). 3(1), 65-7.
Athyros, V. G., Tziomalos K., & Karagiannis A. (2015).  Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.. Expert Rev Cardiovasc Ther. 13(9), 1059-66.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.. Cerebrovasc Dis. 41(5-6), 226-32.
Papagianni, M., Tziomalos K., Kostaki S., Angelopoulou S-M., Christou K., Bouziana S. D., et al. (2018).  Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema.. Am J Cardiovasc Drugs. 18(5), 397-403.
Tziomalos, K., Athyros V. G., Karagiannis A., Kolovou G. D., & Mikhailidis D. P. (2009).  Triglycerides and vascular risk: insights from epidemiological data and interventional studies.. Curr Drug Targets. 10(4), 320-7.
Tziomalos, K., Spanou M., Bouziana S. D., Papadopoulou M., Giampatzis V., Kostaki S., et al. (2014).  Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.. World J Diabetes. 5(6), 939-44.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.